Institutional investors purchased a net $1.6 million shares of RXII during the quarter ended March 2015, and now own 11.62% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TANG CAPITAL MANAGEMENT LLC Bought 1.6 Million shares of Rxi Pharmaceuticals Corp
THE VANGUARD GROUP, INC. Bought 102.6 Thousand shares of Rxi Pharmaceuticals Corp